Joseph Ronald Catapano - 02 Jan 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: Chief Accounting Officer
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 02 Jan 2026
Net transactions value: -$5,416
Form type: 4
Filing time: 06 Jan 2026, 16:05:06 UTC
Previous filing: 03 Oct 2025
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Catapano Joseph Ronald	Chief Accounting Officer	C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK	/s/ Adam C. Vandervoort, Attorney-in-Fact	06 Jan 2026	0001714468

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+2,083	+39%		7,444	02 Jan 2026	Direct	F1
transaction	TDOC	Common Stock	Sale	$5,416	-758	-10%	$7.14	6,686	05 Jan 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-2,083	-12%	$0.000000	14,584	02 Jan 2026	Common Stock	2,083		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.